Index
Grant: University of Cape Town — Tuberculosis Vaccine Preclinical Development and Testing (Coefficient Giving → University of Cape Town)
Verdictconfirmed95%
1 check · 4/9/2026Deterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Our claim
entire record- Name
- University of Cape Town — Tuberculosis Vaccine Preclinical Development and Testing
- Amount
- $597,557
- Currency
- USD
- Date
- June 2024
- Notes
[Scientific Research] Open Philanthropy recommended a grant of $597,557 over two years to the University of Cape Town to support preclinical development and testing of a tuberculosis (TB) vaccine, led by Dr. Thomas Scriba. The approach to the vaccine follows a 2022 study by Musv… expand
[Scientific Research] Open Philanthropy recommended a grant of $597,557 over two years to the University of Cape Town to support preclinical development and testing of a tuberculosis (TB) vaccine, led by Dr. Thomas Scriba. The approach to the vaccine follows a 2022 study by Musvosvi et al. that identified four TB proteins associated with natural clearance of the infection. The proposed research aims to support preclinical analysis of these four proteins in human cell and mouse assays to evaluate their potential as vaccine candidates. This is one of three grants we’re making to support this work. This falls within our focus area of scientific research.
Source evidence
1 src · 1 checkconfirmed95%deterministic-row-match · 4/9/2026
- Name
- University of Cape Town — Tuberculosis Vaccine Preclinical Development and Testing
- Grantee
- University of Cape Town
- Focus Area
- Scientific Research
- Amount
- $597,557.00
- Date
- June 2
NoteDeterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Case № X3h5lT3gXhFiled 4/9/2026Confidence 95%